Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to -$112000.0.

  • Standard Biotools' Cash from Financing Activities fell 550000.0% to -$112000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.6 million, marking a year-over-year decrease of 1114.28%. This contributed to the annual value of -$102.6 million for FY2024, which is 140706.42% down from last year.
  • As of Q3 2025, Standard Biotools' Cash from Financing Activities stood at -$112000.0, which was down 550000.0% from $108000.0 recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Cash from Financing Activities registered a high of $213.0 million during Q2 2022, and its lowest value of -$54.5 million during Q4 2024.
  • Over the past 5 years, Standard Biotools' median Cash from Financing Activities value was -$133000.0 (recorded in 2021), while the average stood at $7.2 million.
  • Per our database at Business Quant, Standard Biotools' Cash from Financing Activities skyrocketed by 16021879.7% in 2022 and then tumbled by 2318000.0% in 2023.
  • Standard Biotools' Cash from Financing Activities (Quarter) stood at $7.3 million in 2021, then plummeted by 103.7% to -$270000.0 in 2022, then plummeted by 271.48% to -$1.0 million in 2023, then plummeted by 5335.69% to -$54.5 million in 2024, then surged by 99.79% to -$112000.0 in 2025.
  • Its last three reported values are -$112000.0 in Q3 2025, $108000.0 for Q2 2025, and -$46000.0 during Q1 2025.